Interactive Transcript
0:00
This was an example of a patient that had bilateral
0:05
enhancing lesions involving both orbits.
0:09
And if you look at this image here on the left hand side, um, Courtney,
0:13
you can see my, uh, arrow, right? Yes. Okay.
0:16
So you can see this abnormal enhancement. This abnormal enhancement is,
0:20
it's actually within the muscle cone itself. So this would,
0:23
if you will be a true intracon lesion. And then on the right hand side,
0:28
a part of this is intracon, but there's also a part that's if you will,
0:32
extending extra conal and also involving the medial portion of the,
0:35
of the orbit. Now, in this particular case, um,
0:40
there are a couple things that can give you this differential diagnosis.
0:43
So there's, when I work through a case like this,
0:47
the things that I start to think about are my differential would be, um,
0:52
lymphoma, I would think of pseudotumor.
0:56
I would think of IgG four associated disease. I would think of sarcoidosis.
1:01
And then I would think of,
1:02
of what we used to call Wagners is poly polyangiitis, granulomatosis,
1:08
um, s So those are the things that, that I would think about. Now,
1:12
how can we help kind of separate those two out?
1:16
So what I like to do is try to get as much history as I can. And if,
1:20
if I know the patient, ha if the patient has a lot of orbital pain,
1:24
like really screaming orbital pain along with chemosis,
1:27
then that's gonna drive me to the diagnosis of, of pseudotumor.
1:32
Now, I think there is a D W I sequence in here. Uh,
1:36
so lemme pull that up. D diffusion weighted sequences.
1:41
What's sort of like the cur what's in vogue right now is that if you look at the
1:44
a d C maps, and let me find the a d C maps here,
1:48
I think they're in here somewhere. Uh, let's see.
1:52
There it is. So if you look at the a d C maps,
1:59
you can see that the A d C oh no, it's very sensitive.
2:04
There we go. Um, you can see that there's actually low signal on the A D C.
2:09
So what has been written is that lymphoma is associated with
2:14
reduced a d C. Now,
2:17
what I wanna make sure that you understand as a following is that if you see any
2:21
orbital lesion and there's decreased a d c,
2:23
that does not necessarily mean that the abnormality is lymphoma.
2:27
But if you are considering lymphoma and the a d C is reduced,
2:31
and that is supportive of the diagnosis of lymphoma, because if, for instance,
2:35
if this was metastasis, this would also have a decreased a D C,
2:40
but clinically the patient has no history of a primary lesion and there's no
2:44
concern about metastases,
2:46
then this decreased a d c can lead to your differential diagnosis
2:51
that you're dealing with, that you're dealing with lymphoma.
2:54
So in this particular case, um, this was an example
2:59
Of lymphoma. So what I want to do is, um,
3:04
give you a, a quick, uh, again, a little five, five,
3:07
a couple minute thing on some of these lesions, uh, lymphoma and pseudotumor,
3:13
et cetera. So let me bring up that PowerPoint. So when we start to,
3:17
to look at, I think I just showed this slide here again,
3:20
this was that thyroid ophthalm osteopathy versus the pseudotumor. And again,
3:24
we talked about this pseudotumor compared to thyroid, ophthalm osteopathy,
3:28
it tends to involve the muscle tendon. Now, one of the things, let go back,
3:32
let me go back to this one here. So, sorry, this is,
3:35
this is actually where I wanted to be here. So this,
3:38
these are examples of lymphoma. So how do we kind of make the,
3:42
the diagnosis of lymphoma? So I can tell you in my, in my practice, so you know,
3:46
I have an academic practice and, and a clinical practice. And the most common
3:52
entity that I've seen involving the retrobulbar region, the community.
3:56
So if you're not in an academic practice,
3:58
but you're in a community and you see something like this,
4:01
the most common thing that I've actually run into is lymphoma.
4:05
So lymphoma tends to be, um, densely enhancing on ct.
4:09
It can give you this sort of iso intense, uh, uh, intermediate attenuation.
4:14
And what it tends to do also, it sort of surrounds the nerve.
4:17
Now it doesn't necessarily compress the nerve,
4:20
but it sort of surrounds the nerve.
4:22
And you can see how it's sort of infiltrative,
4:24
it's sort of infiltrating this in the sense it kind of seeps into all the small
4:28
little crevices and there's not really any associated with bone erosion,
4:33
uh, with it. So this is the a d C value, and you can see there's decreased a d,
4:38
C. And if you see that, then that can suggest that you're dealing with lymphoma.
4:42
Now, when it comes to pseudotumor,
4:44
there's actually different types of pseudotumor. And this is where for me,
4:48
it gets a little bit confusing in the sense that pseudotumor,
4:53
the entity has been around for a long time. And from a pathological standpoint,
4:57
when they use the term pathologists, use the term pseudotumor.
5:00
Oftentimes they're not really sure what it is.
5:03
And sometimes if they're not sure what it is,
5:05
they'll go ahead and call it pseudotumor. Now,
5:08
pseudo tumors can be classified based on the morphology that we see
5:13
on imaging.
5:14
So there's actually six types of pseudo tumors based on the morphology.
5:19
So if we have a pseudotumor that's involving the lateral rectus muscle,
5:22
then this is referred to as myotic pseudotumor.
5:26
If we have pseudotumor here that's actually involving the sclera,
5:30
then this would be, uh, sclerotic neut pseudotumor.
5:34
If you have the pseudotumor that's involving the nerve and surrounding the
5:37
nerve, then this would be considered perine retic pseudotumor.
5:41
If it involves the lacrimal gland as it seen here,
5:43
this would be the ral type of pseudotumor.
5:45
If it's kind of involving everything in the orbit,
5:48
this is sometimes referred to as a diffuse pseudotumor. And then, um,
5:52
then if you, um, have pseudotumor that's extending into the cavernous
5:56
Sinus, then this is what we refer to as OSA hunt.
6:00
So there's actually six different types of pseudotumor just based on the
6:04
morphology and the extension.
6:07
And these patients typically present with a lot of orbital pain.
6:12
Now, this disease entity is IgG four associated disease. And again,
6:16
this was sort of, kind of came into vogue in the mid two, 2000 tens.
6:21
Between 2010 and 2020,
6:24
we became aware of this IgG four associated disease. Now,
6:28
this is a distinct entity. Um,
6:31
it's the way you make the diagnosis is through histological analysis,
6:36
and it's unclear whether this is a primary disease or versus a response.
6:40
And about 25 to 50% of quote unquote pseudotumor is
6:45
actually IgG force associated disease.
6:48
And typically the symptoms are painless and an enlarging mass.
6:52
And so many of these things in the head and neck that we would call pseudotumor
6:57
or things like T'S disease or kuttner's disease, um,
7:01
these are now sometimes felt to be as due to IgG four associated disease.
7:05
So even things like Hashimoto's. But the, the,
7:09
the thing that I notice, um, when I compare an academic versus a a,
7:14
a private practice is that if you're in an academic institution,
7:18
the disease sometimes is already considered.
7:21
So they will go ahead and test for, um,
7:25
they will go ahead and test for IgG four in the serum levels.
7:29
But oftentimes in the community,
7:31
what I end up seeing is that I'll call up the ophthalmologist and I'll say, Hey,
7:35
you know, what did the path turn out to be? And they say, well,
7:37
it was two pseudotumor. And then I'll say, well, did you test for IgG four?
7:41
And they said, no,
7:42
we didn't test for IgG four because that's not in our regular armamentarium.
7:46
So my point is that if you do see the path come back as pseudotumor,
7:50
one of the things that you should always ask for is did they actually test for
7:55
IgG four associated disease? So these are all forms of pseudotumor.
7:59
This is pseudotumor that was involved in the medial rectus,
8:02
the superior oblique, and, and the superior rectus.
8:05
This was pseudotumor involving the, uh, lacrimal glands.
8:09
And this was pseudotumor extending into the orbital apex,
8:12
into the cavernous sinus, and then also had this, this, this dural involvement.
8:17
So, uh, I think we did have a question here.
8:19
I think the question was how did dcra cystitis versus lacrimal pseudotumor how
8:24
to differentiate? Um, so javid, it's a great question. Um,
8:30
just based on the imaging findings alone,
8:32
it's really hard to differentiate between quote unquote dcra cystitis will be,
8:37
which will be an inflammation versus lacrimal pseudotumor.
8:40
The way that you can differentiate is potentially based on how the patients
8:45
present if they have pain. So in general, if they have a lot of orbital pain,
8:49
that would be suggestive of lacrimal pseudotumor. But if it's dcra cystitis,
8:54
then
8:54
They may not have as much pain. The other thing that, um,
8:59
that I have seen is that if you true have a two D acro cystitis,
9:04
which is involving the lacog gland,
9:06
then it really should be isolated to the lacm gland as
9:11
opposed to pseudotumor, which can be multifocal.
9:15
So what I would do is make sure you look at your search pattern and you look for
9:19
multiple foci, because if you have multiple foci of this abnormality,
9:23
then that would mean more consistent with, um,
9:26
pseudotumor as opposed to daco cystitis. Um,
9:30
can pseudotumor cause venous thrombosis? So another good question.
9:34
So
9:37
I would say that pseudotumor can probably cause compression of the venous sinus,
9:42
but if you actually look of the occlusion or
9:47
thrombus within the superior ophthalmic vein,
9:50
as you would see in something like cavernous sinus thrombosis,
9:53
and I don't think pseudotumor causes that because pseudotumor is more of a,
9:58
a slow term progressive process as opposed to an acute process.
10:02
So I think if there is anything that's involving the superior thalmic vein,
10:06
it probably would be more chronic as opposed to acute.
10:11
Okay, good. Yeah. So, uh, yeah, that's a really great question.
10:14
I'm glad you've mentioned that. So are there any ways to tell, and,
10:17
and the answer is yes. So let me, um,
10:21
let me get out of this and, and I'll show you exactly what I mean.
10:25
So when you show the case of,
10:28
of lymphoma in this particular case,
10:31
yes it does sort of look like meningioma, but if you look at the Coronas, no,
10:35
notice how this is a little bit more extensive.
10:38
But the real thing well I want you to pay attention to,
10:41
and I'm glad you asked the question,
10:42
is that the caliber of the optic nerve in lymphoma tends to
10:47
be preserved. And again,
10:49
the only way I can tell you this is sort of like looking at this over many
10:52
years, but lymphoma, again,
10:55
it's not really a hard compressive lesion because it's a rounding.
10:58
It's really arising from the soft tissues within the orbit itself.
11:04
Now if I go back and I look at this case,
11:08
so this is an example again of a retrobulbar mass that really looks sausage
11:12
shaped and you say to yourself, well this could be an optic nerve glioma,
11:16
could it be meningioma, could it be lymphoma, et cetera.
11:19
But this actually turns out to be meningioma.
11:22
Now the thing about the meningioma is that you've heard about the tram track
11:25
sign. So what meningiomas do is that they actually arise from the dural sheets
11:30
surrounding the orbit and they compress the optic nerve.
11:33
So notice how the optic nerve is actually compressed. So for me,
11:37
the way that I can differentiate meningioma from other entities
11:42
such as this, so this is an example of sarcoidosis, is yes,
11:46
there is enhancement here involving the C S F and the dura,
11:50
but notice how the caliber of the optic nerve
11:52
Is maintained. So for me, the key thing is to look at the caliber.
11:56
And if I see something that's involved in the optic nerve,
11:58
but that underlying optic nerve is narrowed,
12:02
then that's how I suggest a diagnosis of meningioma.
12:05
There was one case that, um,
12:08
that I've seen that was called lymphoma,
12:11
but it actually turned out to be meningioma.
12:13
You could actually tell because the nerve sheath was the,
12:15
the optic nerve was narrowed. So hopefully that answered your question.
12:20
I wouldn't make a list of everything that's decreased a, D, C,
12:23
and then start off with the A D C, I would suggest
12:28
coming up with what you think the diagnosis is based on the
12:33
non a d C images
12:36
and then see if the a d C is supportive of any of those entities.
12:42
Because what ends up happening is that you sort of focus on one sequence and the
12:46
next thing you know, you're like, well, 10 things can be, have decreased a, D,
12:51
C, and then you get confused.
12:53
So I always use a d c as a more confirmatory sequence as opposed to the primary
12:58
sequence. So the thing about things like chondro sarcoma, yeah,
13:02
chondro sarcomas can be low on a d c,
13:05
but is that because the density of the cells is really dense or is it because of
13:09
the calcification? And then then you'll say, well, you know what,
13:13
what about chondro? What about uh,
13:16
mixed con chondro sarcomas that have more of a chordoma
13:20
matrix?
13:21
'cause they can be mixed and then all of a sudden you kind of get confused
13:24
because these are not homogeneous tumors.
13:27
So I always use a d C as confirmatory.
13:29
So I look at everything else and then in the back of my mind, I know, well,
13:33
an abscess can have restricted diffusion and I know that more aggressive tumors
13:38
can have restricted diffusion. So if I'm looking at something and I'm like, Hmm,
13:43
there's the mass, what are the, all the imaging characteristics? And I'm,
13:46
I'm still trying to figure out, hmm, could this be benign or malignant?
13:49
Then I look at the ADCs and if it's decreased a D C and it's a good quality a c
13:53
c, then that drives me to suggest that I'm looking at more of a malignancy.